Viewing Study NCT07206758


Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2025-12-25 @ 10:02 PM
Study NCT ID: NCT07206758
Status: RECRUITING
Last Update Posted: 2025-11-18
First Post: 2025-09-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module